These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11229936)

  • 21. VraH Is the Third Component of the Staphylococcus aureus VraDEH System Involved in Gallidermin and Daptomycin Resistance and Pathogenicity.
    Popella P; Krauss S; Ebner P; Nega M; Deibert J; Götz F
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2391-401. PubMed ID: 26856834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoregulation of subtilin biosynthesis in Bacillus subtilis: the role of the spa-box in subtilin-responsive promoters.
    Kleerebezem M; Bongers R; Rutten G; de Vos WM; Kuipers OP
    Peptides; 2004 Sep; 25(9):1415-24. PubMed ID: 15374645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lantibiotic production is a burden for the producing staphylococci.
    Ebner P; Reichert S; Luqman A; Krismer B; Popella P; Götz F
    Sci Rep; 2018 May; 8(1):7471. PubMed ID: 29749386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity to lantibiotics.
    Saris PE; Immonen T; Reis M; Sahl HG
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):151-9. PubMed ID: 8775975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic.
    Schnell N; Entian KD; Götz F; Hörner T; Kellner R; Jung G
    FEMS Microbiol Lett; 1989 Apr; 49(2-3):263-7. PubMed ID: 2765032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lantibiotics, a class of ribosomally synthesized peptide antibiotics].
    Entian KD; Klein C
    Naturwissenschaften; 1993 Oct; 80(10):454-60. PubMed ID: 8264800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation.
    Meyer HE; Heber M; Eisermann B; Korte H; Metzger JW; Jung G
    Anal Biochem; 1994 Dec; 223(2):185-90. PubMed ID: 7887461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nisin biosynthesis in vitro.
    Cheng F; Takala TM; Saris PE
    J Mol Microbiol Biotechnol; 2007; 13(4):248-54. PubMed ID: 17827976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mode of action of lipid II-targeting lantibiotics.
    Bauer R; Dicks LM
    Int J Food Microbiol; 2005 May; 101(2):201-16. PubMed ID: 15862882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin.
    Kluskens LD; Kuipers A; Rink R; de Boef E; Fekken S; Driessen AJ; Kuipers OP; Moll GN
    Biochemistry; 2005 Sep; 44(38):12827-34. PubMed ID: 16171398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gallidermin: a new lanthionine-containing polypeptide antibiotic.
    Kellner R; Jung G; Hörner T; Zähner H; Schnell N; Entian KD; Götz F
    Eur J Biochem; 1988 Oct; 177(1):53-9. PubMed ID: 3181159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Dynamics Insight into the Lipid II Recognition by Type A Lantibiotics: Nisin, Epidermin, and Gallidermin.
    Panina I; Taldaev A; Efremov R; Chugunov A
    Micromachines (Basel); 2021 Sep; 12(10):. PubMed ID: 34683220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biosynthetic characterization and biochemical features of the third natural nisin variant, nisin Q, produced by Lactococcus lactis 61-14.
    Yoneyama F; Fukao M; Zendo T; Nakayama J; Sonomoto K
    J Appl Microbiol; 2008 Dec; 105(6):1982-90. PubMed ID: 19120645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prokaryote multidrug efflux proteins of the major facilitator superfamily: amplified expression, purification and characterisation.
    Ward A; Hoyle C; Palmer S; O'Reilly J; Griffith J; Pos M; Morrison S; Poolman B; Gwynne M; Henderson P
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):193-200. PubMed ID: 11321573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A von Willebrand factor-binding protein from Staphylococcus lugdunensis.
    Nilsson M; Bjerketorp J; Wiebensjö A; Ljungh A; Frykberg L; Guss B
    FEMS Microbiol Lett; 2004 May; 234(1):155-61. PubMed ID: 15109734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediocin-like antimicrobial peptides (class IIa bacteriocins) and their immunity proteins: biosynthesis, structure, and mode of action.
    Fimland G; Johnsen L; Dalhus B; Nissen-Meyer J
    J Pept Sci; 2005 Nov; 11(11):688-96. PubMed ID: 16059970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide signal molecules and bacteriocins in Gram-negative bacteria: a genome-wide in silico screening for peptides containing a double-glycine leader sequence and their cognate transporters.
    Dirix G; Monsieurs P; Dombrecht B; Daniels R; Marchal K; Vanderleyden J; Michiels J
    Peptides; 2004 Sep; 25(9):1425-40. PubMed ID: 15374646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spermicidal bacteriocins: lacticin 3147 and subtilosin A.
    Silkin L; Hamza S; Kaufman S; Cobb SL; Vederas JC
    Bioorg Med Chem Lett; 2008 May; 18(10):3103-6. PubMed ID: 18042385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.
    Peschel A; Otto M; Jack RW; Kalbacher H; Jung G; Götz F
    J Biol Chem; 1999 Mar; 274(13):8405-10. PubMed ID: 10085071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative studies on the fermentative production of lantibiotics by staphylococci.
    Hörner T; Ungermann V; Zähner H; Fiedler HP; Utz R; Kellner R; Jung G
    Appl Microbiol Biotechnol; 1990 Feb; 32(5):511-7. PubMed ID: 1366437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.